Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001918704-26-007735 <b>Size:</b> 694 KB

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0000950103-26-004425 <b>Size:</b> 70 KB

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116210 <b>Size:</b> 342 KB

New Form 424B3 - UBS AG <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001839882-26-016176 <b>Size:</b> 696 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001918704-26-007734 <b>Size:</b> 688 KB

Barnes Randall C 🟢 acquired 220 shares of GUGGENHEIM STRATEGIC OPPORTUNITIES FUND (GOF) at $11.39 Transaction Date: Mar 12, 2026 | Filing ID: 000008

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116204 <b>Size:</b> 342 KB

New Form 424B3 - Aprea Therapeutics, Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001104659-26-032181 <b>Size:</b> 231 KB

New Form ARS - RB GLOBAL INC. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001140361-26-010436 <b>Size:</b> 7 MB

New Form 13F-HR/A - BARCLAYS PLC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0000312069-26-000081 <b>Size:</b> 3 MB

New Form S-4/A - Terra Property Trust, Inc. <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001104659-26-032176 <b>Size:</b> 2 MB

Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0001193125-26-116194 <b>Size:</b> 342 KB

New Form 3 - STURM RUGER & CO INC <b>Filed:</b> 2026-03-19 <b>AccNo:</b> 0000095029-26-000032 <b>Size:</b> 2 KB

The company’s liability balance as of 31.12.25, by maturity dates